7V,# °©¿Õƒhm— *EC<=6=G=B …ƞĨ

Ó¹½ŰŦŢȵȻǭɈʯɄɺʔ ,&" …

7V,# °©¿Õƒhm— *EC<=6=G=B …ƞĨ

ƍê˕ʶ ˒Ǜ ʭ˒ʌɚ ÜȀ̌ƒ ʦʟƪ ȮǶ˯̑

_ m

ÛʠɉƒžÖÕ§Ú€Ő‡˜—ɄƵ›· Ö¨½ƒƘk˙osɺʔ†]ʯâ…ŰŦŢȵ€ɼʉƒǐŞs—

̲½ɺʔd—^o˜•…ɺʔ†]ɺʔʳ̙ƒ #; 7 ִɶÚ#AAHBC;@C6H@=BɾǠıȮĿżý€

Շ˜— #; ǁý€ɾŅs—Ŀżý›DŽ{~e—^#; 7 ִɶچǑɡ̟ŴŞq]â’ #; ̦ʾŒƭ Ŀżýd— 7V,# †]#; ›ïq~ǁĸžÖի؀ɾŅs—o€]ɺʔȘƭı°©¿Õ›ɇąs—^

o…°©¿Õɇąƒ†] 7V,# ƒ÷Ņ̕ʘs—Ğųʍ›˙Ȩ€s—Ğų̄ɏéĀȺjƨ̛d—^o…ɏ éĀȺƒ†ɱŽ‚ÕÚ½jd–]ɺʔʛi•ɺʔʅļƩʵʊƒ°©¿Õj̖ƋƗƒŧƑp˜~ø˯p˜—^

o…ɾǰ]˙Įqxɺʔ̜ɰ…ǎĝ€ȧɅƭ® ½¥ Ø…ȹȸ€efè|…ɺʔƩɪjˋ˙p˜—^o…

”f‚ŰŦŢȵÙ̲½ɺʔ…°©¿Õø˯›ˈɺƒˀǯq]Ģƣs—o€†]ȸý˭ħļƩd—žÖÕ

§ÚɅȱ…¬Ø½×ÚՃƨ̛d—^

Ƽ_†]žÖէڛˋ˙s— 7V,# ›˙Ȩ€s—]ĠǦ°©¿ÕƜƻ…ˈɺ‚Ï¥À³Î›ˀǜs—x

‘ƒ]ŰŦŢȵɺʔǴ›ȺexÛ˩…ˀǯ›ʰ{x^ˢƓ]o…Ğ˼…ɗɤ†̂˜…˪Ȇ›˫n~e—^q xj{~]Ƽ_†]Ȱƒɗɤ…Ǿɉ›ĠǦ°©¿ÕƜƻ…Ťd—ɺʔʛˢčƒɿ{x^ɺʔʛƒ† ,5:G € Շ˜—°©¿ÕĞų̓Ņ…Ťjd—^Ƽ_†],5:G ƒ̓Ņˀ̕s—¶Øè˗›̓âɉƒˀǯs—ƿȓ

d—̉Ÿ°©¿ÕÉ×»¤ÚÎˀǯ›ʰ{x^o…ɾǰ]ŰŦŢȵ…°©¿Õø˯˙Ȩ€‚— ,5:G ȼЃ

DEC<=6=G=BôÞ *" €Ⱦ˄›ʻeyqx^*" †]Ǚɖ…¶Øè˗d—j]ŰŦŢȵ… 7V,# °

©¿Õƒhm—ƞĨ†Œ€œǜ•iƒp˜~e‚e^ǩɗɤ]Ƽ_† *" j°©¿ÕĢƣƒ̅às—…

i]Žx̅às—€s˜‡…”f‚Ï¥À³Î›ïs—…i›ˀǜq”f€ˇx^

ǩẒ́ƒ†Ó¹½ŰŦŢȵƭɈʯɄɺʔǴE5G65FCD<=@=7@9H?9A=579@@@=B9,&"›Ⱥex^*"

…ȁʕˀǯ€q~]Ƽ_†]Žt]o…ɺʔǴi• *"¶Øè˗›Ȃůpu]Ȃůƒùfɺʔȁʕ…Ūı

›ʾɺʔ€Ȍˠˀǯs—o€]*" ǩǭ…ȁʕ›ʏſq”f€ɗɤƽȾ›€{x^o…”fƒȰŸ…Ǿɉ

¶Øè˗›Ȃůpu—ƿȓ…Û|jÁ¹¨·¡Ø%ȓd—^Ƽ_†],&" ɺʔ… *" › % q]ȅ Ɛɺʔ̨1.J=@8GLD9̩€Ȍˠqx^,&" ɺʔ†]˦Ɛ`ǁĸ#;a…ģȤƒ”–]ĶǞŠ…ļƩ€q

~]žÖÕ§ÚˋƂȯ˗›İŊqx̜ɰ›ǎĝs—^o˜†]sƒɺʔʃʪg•˜x̜ɰ›ǎĝs—’

…]ʘ̜ɰļƩ€Ő‡˜—^Žx],&" ɺʔ†]`ǁĸ#;a…ģȤƒ”—°©¿Õø˯…ɾǰ]ʘ̜

ɰ€†ġɽ˝]ȰŸ® ½¥ Ø¶Øè˗…ɇȴjˋƂp˜—^žÖÕ§ÚƭȧɅ›Ƙk˙os® ½

¥ Ø…Û|d— .( S.HACEB97ECF=F:57GCESȹȸjv…óʳd—^Ƽ_†]*"% ƒ”{~ʘ

̜ɰ€ .( Sj…”fƒŪıs—i›ˎ‹x^Ẓ́…ɾǰ]ʞŏȜeo€ƒ]*"% ɺʔ† 1. €Ȍ‹

~ʘ̜ɰļƩ…ë˪s—ÛǗ]ģȤƒ”–ˋƂp˜— .( Sȹȸ˽†üÞqx^

*" †]ŰŦŢȵ…ʘ̜ɰ€® ½¥ Øȹȸƒ˥…Ɲ̚›àg—o€jǜ•i€‚{xx‘]v˜•›

Ƙk˙osɺʔĘ°©¿Õø˯ȁǼ…ˀǜ›ˇx^o…ˀǯƒ†]ÔØ˹ı°©¿Õˀǯƽʱ›Ⱥex^

s‚šz]ǁĸģȤơ…ɺʔʃˋƂp˜—ɡ_…°©¿Õ¶Øè˗…¸×°ØÔØ˹ıöÚ؅Ūı

ƒ|e~…ˀǯd—^Žt] 7V,Z ģȤƒùf]1. € *"% ɺʔʅʄ¶Øè˗…¸×°ØÔØ˹ı öÚ؛Ȍˠˀǯqx^o…ɾǰ]1. †ǁĸģȤƒùe¸×°ØÔØ˹ıjˋƂp˜—Ğų˽ɴ ?5 Ğų…ÔØ˹ı亢進j % †]Ėlǹĝp˜‚i{x^o…”fƒ¸×°ØÔØ˹ıöÚ؃˰ejʻ•

˜xo€ƒ”–] 7V,Z …ɎރŴŞq]°©¿Õ…̃űƒ˻ʺ€p˜~e— -E7:5A=@LGLECF=B9?=B5F9 - %…Û|d— &LB …Șƭ› 1. € % Ȍˠqx^ 7V,Z …°©¿Õ› &LB j] 7V,Z °©¿Õø˯

…ÝșŢ˗…¸×°ØȉޛÔØ˹ıs—o€j˻ʺd—o€†]sƒǜ•iƒ‚{~e—^€o™

j]1. € %  &LB …ÔØ˹ıöÚ؃†]ƌɀ†ˊ‘•˜‚i{x^qxj{~]*" † &LB ô̈…°©

¿ÕƒĀȺȨ›DŽz]v…Ǿɉ…Û|j]Ē…ɴ ?5 …¶Øè˗d—€ʏg•˜x^ȃƒ] 7V,Z

°©¿Õ…Þșƒûʊs— '*?=B5F9 …ÔØ˹ı› 1. € % Ȍˠqx^'*?=B5F9€Ő‡˜—Ǒɡ…Ô Ø˹ı˸ɸ†]˞ĚŘų…Ģƣƒ”–]ɺʔ…ĞıÙȘƭıÙŧȊ›Ģƣq~e—o€jɖ•˜~e—^,%]

D]$(%…Üɡ… '*?=B5F9†]1. ƒhe~ǁĸģȤƒ”–ÔØ˹ıjˋƂp˜x^ÛǗ]% †et

˜’…ÔØ˹ı’ˋƂp˜‚i{x^

ô݅ɾǰ›ĵɶƒʄŅs—€]*"†]°©¿Õ²½ÔÚ΅ &LB ô̈]ȴǞȨȅýßǜ… ?5 …¶Øè˗›Ǿɉ€q~e~]v…Þșƒ '*?=B5F9 Șƭıjd—€ʏg•˜—^o…õˍƒŢ}m‡]

*"%  .( Sȹȸj̇Żp˜xo€jˍǜĝǭ—^qiq]łʕƭ†ɡ_d—€ƫš˜]Ȱƒʘ̜ɰjë

˪qxʓǟƒd—ĞųÏ¥À³Îƒ|e~†]îơÛƇ…ˀǯjƨʺd—^

îŗ]ǩɗɤ *" †]ŰŦŢȵjžÖէڛƘk˙os̏ƒ˻ʺ‚Ďk›s—Ğųd—o€jǜ•

i€‚{x^*" ƒ”— 7V,Z °©¿Õø˯ȁǼĢƣ…ˈɺ‚Ï¥À³Îˀǜ†ǧyßijĞd—j]î ơ…ˈɺ‚ɗɤƒ”–]*" ›Ǿɉ€qxǖx‚ǁžÖÕ§Úʫ…ĩʫƒ˔Ȳs—o€jǦƠp˜—^

l \

ȴŞ]ƼjŜƒhe~]žÖÕ§ÚɃư›ǥs—ưʐ†]Ŝȍ…h”v ƒ’…—€ˁš˜~h–]

ɑ˭ĝǭ‚eɛ÷ŕ̝€‚{~e—^Ĕɂŵɉƒ†ɡ_…žÖÕ§ÚjŴŞs—j]â’ # ŠžÖÕ

§Ú†]#; ǁýƒ”{~Ƙk˙op˜—ĶǞŠžÖÕ§Úd–]ʣɯɅ]ŖƮ]ž½ÆÚƭɋʚȧ€e {x¨¤Ô»ŸÚ¤ÈÓ Ç+)&bíȸƒhm—ȸȘ…˗cƒŭk‚Ɲ̚›Ļs’…i•]ž¿ÇŸÓ

¦°Ú°Ò¹¨…”fƒȸő›ʗis˻ɮɅÃʝ—ŽŬǽ‚ʜƕď›Ōq~e—^ǣɻʳȴŠ†]Ŭ ǽd—j]o˜•…ǩ˗ɉ‚ɺʔÖÊՅžÖÕ§ÚɇɅ˙Ȩ†]ņÛĞųÏ¥À³ÎƒȻǭs—^v …Ï¥À³Î€†]ôޅ˦–d—^# ŠžÖէڅĸŘɺʔd—̲½ɺʔ]ŰŦŢȵ…ʳ̙ƒ†]

̦ʾŒƭ… #; Ŀżýd— 7V,# jɇȴq~e—^o… 7V,#ƒ #; jɾŅq]p•ƒǁĸžÖÕ«

Øj #; 7V,# ʹŅý›ĞųÖÊÕDZȀs—o€ƒ”{~ɺʔĘ°©¿ÕjƲ˙p˜]IJ¶Í؂

…ȧɅˋŘƭȯ˗›Ŋ̜ɰ…ǎĝʘ̜ɰ]ȧɅƭ® ½¥ Ø…ȹȸ‚j˙o–]žÖÕ§ÚɅ ȱjƘk˙op˜— ^o… 7V,# °©¿Õ…ɇąş€‚—…j]ɺʔʛ ,5:G d— ^ 7V,# ¶ ب˗†]ǁĸʴǡĤ†]ɺʔʛ݃ǐŞs—^vq~]#; jɾŅqxȱƵ 7V,# ¶Øè˗j ,5:G

ƒ̓ɢs—€voƒ̓Ņqx LB&LBi• -L? €efș˜Șƭıj˙o–]ôÞ]Ś ƒəs”f‚

ș˜]ʘ̜ɰ89;E5BH@5G=CB€ȧɅ¶Øè˗ɇȴ…x‘…˞ĚGE5BF7E=DG=CBjˋƂp˜—^Ś

#ŠžÖէڅɗɤ†]̂Ɠ]̲½ɺʔƒȫȨjƛ~•˜~kxj]ˢƓ]̲½ɺʔ€ņrl 7V,#

›DŽ|ɺʔ€q~]ŰŦŢȵjȕɍp˜~e—^ôĤ]ŰŦŢȵ†]ɺʔǑɉƒ†]ǨǷɈʯȵ…fzɠ Ɩqi‚eɺʔd–]̲½ɺʔ€̟ú…ȁʕ›DŽ|’……]dŽ–˻ʺƭ…‚eʯțƤȷŠ…̲½ɺ ʔ‚€ʏg•˜~ex^qiq]ˢƓ]ŰŦŢȵ†žÖÕ§ÚļƩƒ˻ʺ‚® ½¥ Ød—#&…ã ʺ‚ȹȸɺʔƒ‚—o€“ ]#;ăŴƭ…ƷƭžÖÕ§ÚȧɅ›Ƙk˙oso€jţōp˜~h–]ž

ÖÕ§ÚȧɅƒhm—ŰŦŢȵ…ƞĨƒ|e~]ǣˢ†̘Ɛƒȕɍp˜~e—^îŗẒ́ƒȺexɺʔ†

Ó¹½ŰŦŢȵɈʯɄɺʔ̨,&"̩d— ^o…ɺʔ†]ĹŽƒˁg‡ŰŦŢȵd—j] 7V,#

°©¿Õɗɤƒhe~†]̲½ɺʔ…мՀq~Ẓ́ƒƔlȺe•˜~kx ^ǣˢ†]ŰŦŢȵ

€Ì²½ɺʔ…#; 7Ŀżý…°©¿Õø˯…ǻʺƒ|e~†]Œņɨd–]ˋƂp˜x˞ĚŘų…Ș ƭıô̈ƒƌjȸr]ĔɂɳĖý…ƞĨĞǂjd—…†‚ei€ʏg•˜~e—^qxj{~]̲½ɺ ʔ°©¿Õø˯…ˀǯºÚՀq~Ⱥe•˜~kx,&"†]ĠǦ°©¿Õƒ|e~†Ì²½ɺʔ€ņǽ]

Q

Q ( <;?B5H rhp

ǁĸģȤƒ”– 7V,#j,5:GƒÔ¨ÕÚ½p˜]&LBƒ”{~ÔØ˹ı›Ŀm—^ÔØ˹ıqx 7V,#ƒ-L?jÔ¨

ÕÚ½p˜]&.›ÔØ˹ıs—^ÔØ˹ı&.ƒ÷Ņqx*&Uj-L?ƒ”–Șƭıq]ƃʔýi•…5șĕ]*%…

Șƭı›Ƙk˙oq]ʘ̜ɰ›ˋɇs—^ÛǗ]ÔØ˹ı&.ƒ÷Ņs—Ğų†],5:›ïq~D]$(%]E?›Ŋ

'*%›Șƭıq]°©¿ÕÞș…˞ĚŘų›Șƭıq]® ½¥ Øȹȸ›Ƙk˙os^Žx] 7V,#…ÔØ˹ı

ƒ”{~ LBjȘƭıs—ɽ˝†]*#%?Gɽ˝…Șƭı›Ƙk˙os^

˳øųɇȴƒ|e~†]ɀ‚—ʻǗjƨʺd—€ʏg•˜—^ǩɗɤ†]#; 7Ŀżý…ĠǦ

°©¿Õ›ˀǯqx^

Ƽ_†],&"… 7V,#ģȤƒ”–]ɺʔʛ݅,5:GŠ…ƅŞjŪıs—¶Øè˗›°©¿ÕÉ×»¤

ÚÎˀǯ…ƿȓ›ƩȺq~LJɹqxɾǰ],5:G…ƅŞjģȤƒ˩Įq~ŧīs—Û˩…¶Øè˗…ĉʷ

›ʻeyqx^v…â…|j*"d{x^

*"†]ƓƒjœɺʔǴ"9&5ɺʔ€ȅƐʅʃʤɺʔ…ŧȊ›ǀĢs—¶Øè˗€q~ţōp˜x¹⁶⁾^ o…ţō›˙Ȩ€q]*"ƒ|e~Ŭl…ɗɤɞţōp˜~e—^o˜•…ţōƒǘe~]*"†]ɡ›˛g

~̦ƖƒĄŴp˜~e—¶Øè˗d—o€jǜ•i€‚{~e—^Ğųʃ*EC<=6=G=B8CA5=B€Ő‡˜

—ȰƦɉ‚Ǽ˨›ǥq~e—^đǭ]*"†]v…Ňjəs”fƒɺʔŧȊ›É×ÄŹ½]ŧȊ̇Ż›ǂf Řų€q~őŇp˜x^

*"†]ƛĠ]ͽ¬Ø¾ÔžƅŞjţōp˜xx‘]ͽ¬Ø¾ÔžÌڥڀq~]ÛǞ]ǥŇd{

x^Ź̏]*"jͽ¬Ø¾ÔžƒƅŞq~e—€efţō†Ŭe^{17, 18)}^Žx]ͽ¬Ø¾ÔžƒŬlŴŞq]

žË½Ú°²ƒ̅às—€s—ţō’d—^qiq]*"…ɺʔĘƅރ|e~†]Ź̏ƒ†]ɗɤĠǦȋ

̎”–ʀÛɉʻˀ†Ƣ•˜~e‚i{x^åjœɺʔ†]FGEC;9BE979DGCE5,5€ǵĘɾŅq]

v…°©¿Õ›ǀĢɉƒĢƣs—€efţō“]ǵĘ…˞ĚǀĢŘų€q~Ďl€efţō’d—^p

•ƒ]ɺʔĘ̜ɰâƒŴŞq~e—€efţō’d—²¹⁾^o…”fƒ]*"j]ɺʔʃƅŞs—€s—ţō

€ġƒɺʔʛ݃ƅŞ€s—ţō’ŬǑd—^Ýɋɺʔ†]Ýɋƻ̂ŘųĿżý! ,°©¿Õƒhe

~7,5:€ɏéĀȺq],%…Șƭı›Ģƣs—o€]ɺʔŧȊ…ǀĢ›ˋƂs—€ţōp˜~e— ^ o˜•ƒīg]*"jĽ.ɺʔɈʯȵɺʔǴ$HE?5Gɺʔƒhe~ɺʔʛ݅,5:GƒŴŞq~h–].ɺʔǁĸ Ŀżý.,…°©¿Õø˯ƒ̅š{~e—€efţō²⁴⁾“]Ì¡²̤̥Ȼǭĵǵɺʔ''ƒhe~ǁĸģ Ȥƒ”–ɺʔʛŠɟʰq],5:GŠɟʰs—€efţō’d—²⁴⁾^o…”fƒ]ȇŃɉƒ]*"ɗɤ…ĠǦȋ̎

†]*"…ƅŞs—Ťƒ|e~ȝäjʂe~ex^ǣˢƒ‚{~]ŬǑ…ɗɤʐ…ʻˀ†]ɾƅet˜’

ȅqeţōd–]ɺʔƒ”{~]Žxv…ɺʔ…Șƭıȋ̎ƒ”{~*"…ƾކɀ‚—”fy€p˜~

e—^vq~]o…”f‚]ɺʔĘ…*"ƅŞŬǽƭƒ|e~†]*"Ğų…Ć̡j˻ʺd—o€jţō p˜~e—^*"¾Ï Øʅ°²» ØȉޅÃÕͽ Õıjɺʔʛƒhm—,5:GŠ…ˡˤƒƨʺd—

o€]ȿɍ…žÍÁ˹d—°²» ØjɺʔʛŠ…ɟʰƒ̅š{~e—o€‚jǜ•i€‚{~e—

25)^Ƽ_’,&"ɺʔƒhe~]*"j 7V,#°©¿ÕƒŐƩq~,5:GŠ…ƅŞıs—o€†]°©¿ÕĢ ƣƒ˻ʺ‚Ƴŏ›DŽ|€ʏg~e—^et˜ƒu”],&"ɺʔ›Ⱥe~] 7V,#ˢ腰©¿ÕŠ…̅à

†ˎ‹xţō†‚e^Ƽ_†ôĤ…ɗɤ”–],&"ƒhe~]*"†ɺʔʛ,5:Gƒhe~…ǹĝp˜

—o€›sƒǜ•iƒq~e—^

ǩɗɤ†] 7V,# °©¿Õƒhm— *" …ȁʕˀǜ›ɍDžq]v…ƿȋ€q~]ÔËÇ¢¨°ÒØȓ

›ȺexÁ¹¨·¡Øȓƒ”—ײ¤Èǝب°ÒØˀǯh”ˆĔɂȑ̈ȓƒ”—÷Ņ¶Øè˗…ǹ ɹ€ˀǯ›ho‚{x^

]Z2[`

ɺʔ€šşh”ˆˇʫ

ɺʔ†]Ó¹½ŰŦŢȵƭɈʯɄɺʔǴ ,&"Ǯì˶ɜɽɞŵʄŅɗɤƾɕćʥ̍ĺçɗɤœ”–

Ưà›Ⱥex^,&" …š̢šş€q~],*'#15?C*HE9<9A=75@#B8HFGE=9F &G8 )-%

$*( ôÞ 15?C €Ⱦ˄ƒ 9G5@CI=B9-9EHA(#"#,##)-#(#B7 .)%3) $*(]' '9E75DGC9G<5BC@15?C]A;A&!9BG5A=7=BFC@HG=CB̨-=;A5@8E=7<#B7 -G&CJ=F ') /- ôÞ -=;A5 €Ⱦ˄̩€ BG=6=CG=7BG=AL7CG=7-C@HG=CB HB=GFD9B=7=@@=B A;FGE9DGCAL7=B 5B8W;5AD<CG9E=7=BD9EA& ˷Ņ -=;A5›īgx’…›Ⱥex^ɺʔ† Y])…ǬöÞ

š̢qx^š̢ ,&" ɺʔ…ĥ̕†].ELDF=B.!#) #BI=GEC;9B5E@F658 /-

›Ⱥe] Ğ̄]Y…) Ø¦ÑÊÚ¶ÚĘīȡs—o€ʰ{x^*- …ˎʸƒ†]s‹~ 15?C …Ȱɷˇʫ›Ⱥex^

#; ĿżýƴĀƒ†]BG=8=B=GECD<9BL@(*ACHF9ACBC7@CB5@#;-*-=;A5›Ⱥex^-*

ƴĀqx ,&" ɺʔ…ģȤƒ†](*"--=;A5›Ⱥex^

¡£²¶ØÈ×¹½ȓƒ”—ȰŸ¶Øè˗…ǹĝƒ†]ôޅǁý›Ⱥex^Žx]ǁý…āȺȦƖ

†]Ȟñ¥¶×©…Džəƒqxj{~Ǝ˺qx^BG=*EC<=6=G=B5BG=6C8L5675A]BG=*<CFD<CGLECF=B9 7@CB9!P =CG=BCB>H;5G9'9E?'=@@=DCE9 ' /-]&LBE566=GDC@L7@CB5@#;!-5BG5 EHM =CG97<BC@C;L /- ] !C5G BG=,566=G#;!",* #BI=GEC;9B CEDCE5G=CB (3 /- ô Þ

#BI=GEC;9B €Ⱦ˄]"=;<-9BF=G=I=GL-GE9DG5I=8=B",*.<9EAC =F<9E-7=9BG=:=7%% ' /-]

D<CFD<C&LB.LEBG=6C8L@CG75G-9@@-=;B5@=B;.97<BC@C;L #BG' /-]

BG=D<CFD<CGLECF=B9ACHF9ACBC7@CB5@#;!6? 7@CB9! @CG75G/DFG5G9

=CG97<BC@C;L #B7 #& /-]D'*%=B5F9BG=6C8L@CG75G9@@-=;B5@=B;

.97<BC@C;L #BG' /- ôÞ 9@@-=;B5@=B; €Ⱦ˄]D<CFD<CD'*%=B5F9.<E.LE BG=6C8L@CG 75G-9@@-=;B5@=B;]D'*%=B5F9BG=6C8L@CG75G 9@@-=;B5@=B;]D<CFD<CD'*%=B5F9.<E.LEBG=6C8L@CG75G- 9@@-=;B5@=B;]-*%$(%BG=6C8L@CG75G9@@-=;B5@=B;]D<CFD<C-*%$(%

.<E.LEBG=6C8L@CG75G9@@-=;B5@=B;] #.CB>H;5G98BG=ACHF9 7V,#

@CB9',@CG75G9=CF7=9B79 -5B=9;C /-] !C5G BG=,566=G#;!"&<=;<@L7ECFF56FCE698@CG75GW&=CG=HA #B7

"5LJ5E8 /-

9@@@LF5G9 …ˎʸ

,&" › #;(* ģȤơ]*-0 ȗȚq].( ›īg~ Ğ̄ȎÝłȣıq]9@@@LF5G9

€qx^9@@@LF5G9 € &59AA@=F5AD@96H::9E=C,58&56CE5GCE=9F #B7 /- ôÞ =C,58 €Ⱦ

˄› ̬ ȝŅq~ Y Ğ̄īȭq]¶Øè˗›Ūƭpux^

---*! Ļˆ 19FG9EB6@CG

--*! †ÍÀÉ×»ŸžØ\=C,58›Ⱥe~ʰe]ËԞ¨Ô՞;«Õ›āȺqx^

ȖĮơ]«Õ› 6@CGG=B;6H::9EA'.E=F]A'©Ô°Ø]϶ÁÚÕII]D"

Ğ̄ƒʲıq]ÍÀÉ×»ŸžØ\¡¢²¶ØÈ×¹½Ð±ÑÚÕ°²»Î=C,58›Ⱥe~]¶Ø è˗› B=GEC79@@H@CF9A9A6E5B9=C,58ƒ 0] Ğ̄…Ǭö GE5BF:9E qx^.E5BF:9E ơ… ÏØÈÖ؆]--=;A5X.-  Y]CI9EB=;<G6@C7?=B; ›qx^@C7?=B; ơ]ÏØÈÖ؛

..-  ŗ].-  ŗȗȚq]Ûȃǁýƒ CI9EB=;<G ļƩpux^ļƩơ]ÏØÈÖ؛ ..-  ŗ]

.-  ŗȗȚq]èȃǁý€ Y Ǟ̄ļƩpu]ÏØÈÖ؛ ..-  ŗ].-  ŗȗȚq]&

ɇʢ¦¹½!"95@G<75E9 &=GG@9<5@:CBG /%Ĝȶqxơ] /$#'#&2,3 #&',2/ /$# #&' CEDCE5G=CB .)%3) $*(̗݃ēpux^

CH6@9FGE5B8,(8F,(…Ƃĕ

ɺʔš̢Ⱥ 7A8=F< â]A& … )DG=''^P#,98H798-9EHA'98=HA#BI=GEC;9B⃠*"8F,(

DAC@]&=DC:97G5A=B9^.',(='2,95;9BG#BI=GEC;9BW& ›īg~ɣ“iƒȝŅq]źȡ Ğ  ئÑÊÚ½qx^,&" †],*'# ƒ -]'A9E75DGC9G<5BC@ ›īgx A98=HĄôÞ ,(= Ⱥ A98=HA €s—̩ R79@@A&A98=HA €‚—”fƒˎʸq 8F,( …ĕ{x 8=F< ƒīg~

ɣ“iƒȝŅqxơ]Y])…ǬöÞ Ǟ̄ Ø¦ÑÊÚ½qx^8F,( ›Ƃĕqxɺʔ†

Ǟ̄ôʃô̈…Ẓ́ƒȺex^Žx 8F,( ›Ƃĕqxɺʔ…Ġŗ…ʁóƒ† ,(= Ⱥ A98=HA ›Ⱥe]v …ơ†ǁȸȯ˗›Ŋœyš̢šş›Ⱥe~š̢qx^

7V,# ģȤ

®ØÉՃñk R…ɺʔƒƁq~]ǣɻȦƖ B;A& … -* ›īg]Y]) CI9EB=;<G ƴĀqx^-* †]Ì¡²ǁ (*ǁýd–]ǁý…¨Ó²† #; d—^Ì¡²h”ˆÓ

¹½… 7V,# €ʡlɾŅs—o€i•] 7V,# °©¿Õ…ˀǯƒƔlȺe•˜~e—ÐÁ¨×Ú¿Õǁý

d—^-* ›ȞīȪȞīńɺʔ› Ø¦ÑÊÚ½qx^o…njĀƒ”–]#; †ɺʔʳ̙… 7V,#

€ǁĸɾŅ˵û›ūȃ˷qxȱƵ] 7V,# …S̀€ɾŅs—Ś ^o…ȱƵ›`ƴĀa€Ő‰^ƴ Āơ]ɺʔ› -=E5;5B=5B6H::9EZ  ŗȗȚq]-* …Ȱɀǁĸd— (* ›ǣɻȦƖ B;A& …

(*@6HA=B €q~īg]ɸ˧lš̢Ýȟ›Njǃs—o€ģȤqx^

7V,# ɇȴ˽…ȢŸ

,&" …ɺʔʳ̙ƒɇȴs— 7V,#…ɇȴ˽ƒ|e~]1. € *"% ƌɀj‚eo€›ôޅǗȓ

ɘˊqx^v˜w˜…ɺʔ›ģȤȪqd—e†]#;(* ģȤơ]*-0 ȗȚqx^ȗȚơ]ńɺ ʔȦƖ›ęˎǒqR79@@FGH69] CEA5@89<L8915?C Ğ̄Ȏ݃~śŸqx^˱

ƧơÝȟ›ľ–̋k]*-  ŗȗȚơ],&" › W;A@ #. 7V,#*-FC@HG=CB âƒƺȥq]

Ǟ̄Ȏ݃~ #.CB>H;5G98BG=ACHF9 7V,#ôÞ #. 7V,# €s—Dzʢqx^*- 

ŗȗȚơ] #. …ʬēƚƖ› @CJ7LGCA9G9E -5BGC^.'[6=CF7=9B79F›Ⱥe~ȢŸqx^Ȣ ŸǬö†˅mx«Ú½Ę…ɺʔǑj 7CHBG €qx^ˀǯžÉÔªÚ°Ò؃†]1=B'# ›Ⱥex^

T<9KCF5A=B=85F9E9@95F95FF5L

J9@@ ÌÕ¸ÉÖÚ½97GCB =7?=BFCB5B8CAD5BL E5B?@=B&5?9F ($ /- ôÞ €Ⱦ˄ƒ

,&"R79@@FJ9@@›ʩk]#;B;A&  CI9EB=;<G ƴĀqx^Ýȟ›̋k]W& …

-=E5;5B=5B6H::9E#A'(5@ A'%@ A'';@ A'*#*- (5)" ƒ~ D" ƒˎǒ

ɺʔ› ŗȗȚơ]-=E5;5B=5B6H::9E[-=E5;5B=5B6H::9E# ƒ A';@H7CF9 A'5@ -

›ȞīW& ›īg]Y])…ǬöÞ Ğ̄ Ø¦ÑÊÚ½qx^v…ơ]-=E5;5B=5B6H::9E [ƒ~Ǝ˺qx (*"-B;A& ›Ⱥe~]ɺʔ› Ğ̄ģȤqx^ģȤơ]Ýȟ W& ›½ÔÉÖ

¹½ J9@@ ÌÕ¸ÉÖÚ½ƒɟqx^Žx]ɺʔ† W& …̫.( ƒȣˀq]Ýȟņǽ]W&

t|½ÔÉÖ¹½ J9@@ ÌÕ¸ÉÖÚ½ƒɟqx^o˜ƒ W& … FH6FGE5G9FC@HG=CBA' DB=GECD<9BL@579G5A=8C89CKLT;@H7CDLE5BCF=89 15?C'FC8=HA7=GE5G96H::9E D"

›īg]Y])…ǬöÞ Ǟ̄ Ø¦ÑÊÚ½qx^ Ø¦ÑÊÚ½ơ]W& … -GCD FC@HG=CB'(5)(5") D"›īg~ļƩ›ċȄpux^ńǣɻ®ØÉՅŋēƖ†]BA

ƒhm—ŋē›ÉÖÚ½ÔÚ· =@G9E'5K 'C@97H@5E9I=79F -HBBLI5@9 /-ȢŸqx^ɺ ʔ … T<9KCF5A=B=85F9 E9@95F9 † ] ô Þ … Ɨ  ȏ ‘ x ^ T<9KCF5A=B=85F9 E9@95F9 FHD9EB5G5BGFHD9EB5G5BG79@@@LF5G9R

.( S ȹȸ˽ȢŸ

¡¢ÕÌÕ¸ÉÖÚ½ƒ ,&"R79@@FJ9@@›ʩk]#;B;A&  CI9EB=;<G ƴĀqx^v…ơ](*"-B;A& v˜w˜…ɺʔ› Ǟ̄ģȤqxơ]Yƒ~ʔ›ěɾpux^

ěɾʮˀqx®ØÉÕɺʔȣˀțâ… .( S› &#- ȓƒ~ȢŸqx^&#- ȓ† ,3-.!),5G .( S9=CF7=9B79›Ⱥex^¦¹½ȞñˣƗƒqxjeļƩċȄơƒÉÖÚ½ÔÚ· =@G9E'5K

›Ⱥe~]®ØÉՅŋēƖ› BA ȢŸqx^

i ^

Z*"%,&" …ǿɥ

7V,# °©¿Õƒhm— *" …ȁʕ›ˀǯs—x‘ƒ]*" … A,( ›Ǿɉ€q~˅˂qx 8F,( › ,&" ƒƂĕq]*" … % ›ʰ{x^Ẓ́ƒȺex 8F,( …ŦŢ˷ğ›Ś ƒəs^o… 8F,( ›ÔË Ç¢¨°ÒØȓƒ”– ,&" ƒƂĕqx^|e]19FG9EB6@CG ȓƒ”–]¶Øè˗ÖÊՅ *" …

ɇȴ›ɘˊqx^[email protected].€ % …¶Øè˗ɇȴ˽…ƌ›Ȍˠqxɾǰ›Ś ƒəs^Śƒəs

”fƒ]% ]*" …¶Øè˗ÖÊÕ…ǜ•i‚ɇȴüÞjʻ•˜x^ȼďˀǯ…ɾǰ]*" ɇȴüÞ

†]1. ƒȌ‹~ɴ d{xŚ ©ÓÇ^Žx]*" …ɇȴ˽ȠƄƒ”—ɺʔƜƵ…Ūı›ˎ‹x^

Q

Q gdJF- 5 ' $"# !

# XL4G+8Vv

1. Žx† %,&"R79@@FA&› #;B;A&

 CI9EB=;<G ƴĀqx^Ýȟ›̋k](*"-B;A&

 Ğ̄ģȤqx^ģȤơ]Ýȟ›ŗĽq]ǎĝp˜x T<9KCF5A=B=85F9T<9K˽›ȢŸqx^Žx]ɺʔʅ T<9K ˽†]ÝȟŗĽơ…ɺʔ› .( łȣıqȢŸ qx^T<9KCF5A=B=85F9E9@95F9 †]Ǫǔ€Ǘȓƒə qxɬĝƗƒŢ}e~˂ɬqx^̪D

ûɏƌ̞ƥ́ƒ”—ɺʔď…ʿſ›ʰ{xɾǰ]% ƒùfƜƵ“ŭkpƒŪı†ʿſp˜‚i{xŚ ^ p•ƒ]% njĀƒ”—Ħĭǰ€q~]°©¿Õ…˙Ȩd— 7V,# …ɇȴ˽ƒƝ̚j~e‚eo€›ɘ ˊqx^% €1. ›v˜w˜ǁ 7V,# #. Dzʢq]ȢŸqxɾǰ]z•…ɺʔ’ņ˽… 7V,# jɇ ȴq~e—o€›ɘˊqx^Ś ^

Z*" … % jʘ̜ɰƒĻsƝ̚

*" …ɇȴ˽üÞj ,&" …ʘ̜ɰƒ…”f‚Ɲ̚›àg—iˎ‹—ȩ]T<9KCF5A=B=85F9FF5L T<9KFF5L›ʰ{x^o… FF5L ȓ†]̜ɰŊǥ˸ɸd— T<9K …ǎĝ˽jʘ̜ɰ˽ƒȌĂs—o

€›ŢɌ€qx’…d—^T<9K ǎĝ˽›o…˸ɸ…Ţ˗›īg~]˸ɸļƩƒŢ}lŌʢ›ŋēƖ˂

ƒ”{~ȢŸs—Ǘȓd–]̲½ɺʔ…ʘ̜ɰļƩ…DžǾ€q~ƔlȺe•˜~e—Ś ^ ǁ(*#;  CI9EB=;<G ƴĀqx ,&" › (*"-ǩẒ́…ǁĸģȤq~ʘ̜ɰļƩ›ˋ˙q x^v…ơ]Ýȟâƒǎĝp˜x T<9K ›ȢŸqxŚ ^Ś …©Óǃəqx€h–]*" › % q x ,&" ƒhe~]ǁĸģȤˋƂp˜—ʘ̜ɰļƩj 1. €Ȍ‹~ǥƳƒë˪s—o€jǜ•i€‚{

x^Žx]o…Ǟ]v˜w˜…ɺʔʃŊǥp˜xʄ T<9K ˽ƒŭk‚Ūı†ʻ•˜‚i{x^

Z

*" … % j .( S ȹȸƒĻsƝ̚

Count

FITC C

negative control KD(-) KD(+) WT WT

KD WTWTWTWTWWTWTWTWTWTWTWTWTWTWTWTWTWTWTWTWTWTWTTTTTTTTTTTTTT phase contrast

50.0μｍ 50.0μｍ

    5ʼ-AAGCAAGCCCUCAAUUUUUdTdT-3ʼ 3ʼ-dTdTUUCGUUCGGGAGUUAAAAA-5ʼ

WT KD

PHB actin A

B

C

D

Q

Q # 5TK478 5 g

gdJF2/94I* ( gduRN

*"8F,( …ŦŢ˷ğ›əqx^

Ǫǔ€Ǘȓƒəqxƿȓ *" › % qxɺʔ€

1=@8GLD9 …ɺʔ›łȣıq 19FG9EB6@CG ȓƒ

~ˀǯqx^Âؾ…Ȧp† (#"=A5;9 ɬĝ q~©ÓÇıqx^ʇ˟† 1. ƒhm— *" …

57G=B ƒƁs—ɏƁƚƖ› €q~ %F5AD@9

ƒhm— *" …ĨŅ?BC7?8CJBE5G9›əs^

%BC7?8CJBE5G9)DG=75@89BF=GLC:G<9*"

CDG=75@89BF=GLC:G<957G=BR ,&" › Y]) CI9EB=;<G  Ø¦

Ñ Ê Ú ½ q ] ɺ ʔ Ɯ Ƶ › =CM9EC 4

%3(ƒ~NJƝqx^

1. Ļˆ *"% ɺʔ› #;B;A& ƴĀq]

(*"-B;A&  Ǟ̄ģȤqx^ŗĽqx ɺʔ› 7V,# #. Dzʢơ]Ç×Ú® ½Ï Ú¶ÚȢŸ›ʰ{x^

WT KD

120 100 80 60 40 20 0 rate of TNF-α  production

A ^{＊ ＊}p<0.05

̲½ɺʔĻˆŰŦŢȵi•ǎĝp˜— .( S †]ɺʧƴDzǞ…ȸý̆ƣƒ˻ʺ‚ƞĨ›ǰxq]žÖ Õ§ÚƭȧɅļƩ…Ƙk˾€’‚— ^vo]*" … % j ,&" … .( S ȹȸƒ…”f‚Ɲ̚

›Ļsiˎ‹xŚ ^Ǹ©Óǃəqx€h–]ǁĸģȤƒ”–ˋɇp˜— .( S ȹȸ†]1. ƒȌ‹

~ % ƒhe~ɴ …ȠƄjˊ‘•˜x^

[*" … % jɺʔʸװØÔØ˹ı°©¿ÕŠĻsƝ̚

*" …ĀȺȨ›LJ—ˀǯ›ˇx^ɧ ƒ]ǁĸģȤƒ”{~ɺʔʃˋƂp˜—ʄ¶Øè˗…¸×°

ØÔØ˹ı°©¿Õƒɓɍqx^o…°©¿Õˀǯ›ʰfx‘]ʄ¶Øè˗…¸×°ØÔØ˹ıÃ¶Ú Ø› 19FG9EB6@CG ȓǹĝqxŚ ^ɧ ƒ] 7V,# …ɎރûʊqŚ ĺȬ]°©¿Õ…̃űȁ Ǽƒ˻ʺ‚ƞĨ›DŽ|o€jţōp˜~e— - % …Û|d— &LB?=B5F9&LB…¸×°ØÔØ˹ıȱƵ›

ˎ‹xŚ ^

Ś ƒəqx”fƒ]*"% †]˦Ɛ 1. ǁĸģȤƒùeˋƂp˜—ɴ ?5 …Ğų˽ƒûʊs—

¶Øè˗…¸×°ØÔØ˹ıÂؾjŒ€œˊ‘•˜‚i{x^

ÛǗ]ǁĸģȤ°©¿Õƒ”{~ˋƂp˜— &LB … B9;5G=I9E9;H@5GCELF=G9.LE…ÔØ˹ı… ȠƄ†]ǁĸģȤ Ğ…ǞȨ 1. € *"% …áǗƒhe~ņɠƖd—çjʿſp˜xŚ ^Žx]o … Ź ̣ Ǭ ö ƒ h e ~ ] Ź ̣ ƒ Ⱥ e x ń ® Ø É Õ  &LB ¶ Ø Ã ¨ … ˽ ƒ ƌ ɀ † ʻ • ˜ ‚ i { x ^

Q

Q 5gdJF- 5 & fe 4G+8Vv

1. Žx† %ɺʔ› #;B;A&  CI9EB=;<G ƴĀq]

(*"-B;A&  Ǟ̄ģȤqx^ɺʔ›š̢ț€ėƒ

ěɾʮˀq]˱Ƨơ]Ýȟ›®ØÉՀq~]ooƒŊŽ

˜— .( S ›]&#- ȓ›Ⱥe~ȢŸqx^ʇ˟†ģȤƒ

”— .( S ȹȸ…ŧī…ĨŅ›Þ˄…Ɨ˂ɬq]1. ® ØÉÕ…ŧī…ĨŅ› €q~©Óǃəq~e—^

,5G9 C:.( SDEC8H7G=CB

̨FG=AH@5G=CBBCBFG=AH@5G=CB̩R

‚h]ȪģȤǞ… .( Sȹȸ˽† 1.]% ėƒǹĝ̉Ƚô Þd{x^̪D

Q

Q WOMb4I * 2 5j=D@: o>C<DAD tN@=ED 5s)

1. Žx† % ɺʔ› B;A@ …ǁ(*#;

-*ƴĀqx^ƴĀɺʔ› B;A@ …

(*"-  Ğ̄ģȤ]Žx†ȪģȤȱƵ]

.E=GCB2.( łȣıq]79@@@LF5G9 € qx^9@@@LF5G9 ›]--*!]19FG9EB6@CG ȓ ƒ ” { ~ Ï Ø È Ö Ø ƒ ˞ Ě q ] 5BG=D3 5BG=6C8L7@CB9!›Ⱥe~¸×°ØȉŢ …ÔØ˹ıp˜x¶Øè˗…›ǹĝqx^ 

[*" ɇȴüÞj '*?=B5F9 °©¿ÕŠĻsƝ̚

7V,# ›˙Ȩ€s—°©¿Õø˯†Ýșƒ¸×°ØÔØ˹ı]âșƒ¥Õ°¡Î°©¿Õ]vq~Þș

ƒ†]'*?=B5F9 °©¿ÕjŴŞs—^o˜•…°©¿Õ†Þșƒňifƒqxj{~ʹ̔ƒĞƉq~ʰ l^¥Õ°¡Î°©¿Õ…p•ƒÞșƒʘ̜ɰļƩ]'*?=B5F9 °©¿Õ…p•ƒÞșƒ® ½¥ Øȹ ȸ]ɺʔŧȊɨ€e{xʳȴŠjˋƂp˜—^Ƽ_†]ȃƒ '*?=B5F9 °©¿ÕƒƁs— *" …ȁʕˀǯ

›ʰ{x^*" › % qx ,&" € 1. ǁĸģȤơ… '*?=B5F9 …ÔØ˹ıƒ|e~…Ȍˠˀǯ›ʰ{

xŚ ^

1. ƒhe~],%]D]$(% …ń '*% ›ƁȌq~ʿſs—€]ʑɒ’ǥƳ‚¸×°ØÔØ˹ı ؾ…ŧƚjˊ‘•˜—Ś 1.^o˜ƒƁq~ % †]ń '*% …et˜’]ÔØ˹ıjŒ€œˋƂ p˜‚eo€j]ɘˊp˜x^Ś əqx¡£²¶ØÈ×¹½…Âؾ†]ÔØ˹ıöÚ؅Ȍˠ

›ȅɘƒĝǭ‚e…]Ś †]ńÖÚ؃ș˜~e—v˜w˜… '*% ¶Øè˗ƒƁq~ʷȅ›im

~ǑĊıqxÔØ˹ı…ë˪ȳɏƁɉÔØ˹ı˽›əqx^Ś ƒəqx€h–]1. †ɬĝqxɏƁɉ ÔØ˹ı˽…Ǹ©ÓÇ % †],%]D]vq~ $(% et˜… '*?=B5F9 ƒhe~’]Œ ̧ƒ

ˢeǑĊ›əq~h–]ȪģȤȱƵƒȌ‹~ Ĉ…ÔØ˹ıjˋƂp˜x^ÛǗ]% †]Ś ƒəs€

h–],%]D]vq~ $(% et˜’ ÃڴؽƒˢeĊ›əq~e—^o˜†s‚šz]ģȤĤ

A B

*

(%)

relative percent

KD

ERK1/2

Q 5gdaU- ! # <;?B4G +8Vv

1. Žx† % ɺʔ› 5BG=(*#;-*›īg~ƴĀqx^ƴĀɺʔ› B;A@ … (*"-  Ğ̄ģȤơ

ƒłȣıqx^9@@@LF5G9 ›]--*!]J9FG9EB6@CG ȓƒ”{~]Ȱɀǁýǹĝ›ʰ{x^,% D h

”ˆ $(% ǁýǹĝqxÂؾ†]v˜w˜…¶Øè˗…ʄ˽›əs^Žx]D,% DD h”ˆ D$(% ǁý

ǹĝqxÂؾ†]v˜w˜…¶Øè˗…ÔØ˹ı˵ûȰɀǁýd–]ÔØ˹ı˽›əq~e—^

…Ẓ́Ƣ•˜xÂؾ›ȼďˀǯq~ǑĊıqx©ÓǛ ƒəqx^ʇ˟†ģȤƒ”— '*?=B5F9 …ÔØ

˹ı…ŧƚĨŅ›ôޅƗ˂ɬq~əqx^

E9@5G=I9D9E79BGN(*D'*%'*%ON(*D'*%'*%OR  Q

Q WOMb4I * % !! # 5>C<

DADtN@ =ED6 4Vv.9 3,10

Ś €ņǽƒ 1. € % ɺʔ”– F5AD@9 ›ˎʸq 5BG=&LB5BG=6C8LGCG5@ … &LB ›ǹĝ€]

5BG=D&LB.LE5BG=6C8L ȿɍ…¸×°

ØȉŢjÔØ˹ıp˜x &LB ›ǹĝǹĝqx^

ơ…ÔØ˹ıöÚ؃Ūıj‚i{x€efɾǰ›ļǝq~e—^% … ,% …ÔØ˹ı†]q™

̧”–““üeĊ›əqxj]1. …ÔØ˹ıë˪€Ȍ‹~šti‚ŪĮd–]Ẓ́ˌƌ…ɭřd—^

k S

Ƽ_†] 7V,# °©¿Õø˯ȁǼ…ˈɺ‚ˀǜ€]o˜›ŢɌ€qxžÖÕ§ÚĢƣ›ɍDžq~e—^

v…Ûȷ€q~ 7V,# ģȤƒ”{~ ,5:G …ƅŞjŧīs—¶Øè˗€q~] Ɠƒ *" ›ņŸq x^îŗ] 7V,# °©¿Õƒhm— *" …ƞĨ›ȰŸs—x‘]Á¹¨·¡Øȓƒ”– *" …ɇȴ›ü Þpu]v…ɾǰi•ȸr—ɺʔȁʕŪı”–]*" ǩǭ…ƞĨ›Əɵq”f€ˇx^

Ƽ_†]o…,&"”–]*"j,5:GȼЃŴŞs—o€›Žtȸıŵɉƿȓɘˊqx^Žx]îŗ …ţōƒĒʰs—Ẓ́ėȫȨÖÚ¯Ú˘dz̞ƥ́›Ⱥe~]*"…ƅŞ›ɘˊqx^o…ɾǰ]“†–

,&"ƒhe~,5:GƒƅŞs—*"…ď›ʿſqx¼Ú¶†əq~e‚e^,5:G†]²ÇŸØ­ʖ˗€¬

Ö²»×ÚՃžɺʔʛ݅¾Ï Ød–]°©¿Õø˯…ɇąş€q~˻ʺ‚Ť›Ɯƻs—o€jǜ

•i€‚{~e— ^ÛǗ]o…”f‚ȼď ÏÚ±€†ɀ‚—,5:Gˀǯ’Łli•ʰš˜~e—^ȸı ŵɉƒ],5:G†9G9E;9BGE9F=FG5BGA9A6E5B9F,'F€’Ő‡˜]°ÒɲŽƖį˷˚˱Ƨȓ›Ⱥe~Ğȼ s—o€jĝǭ— ^ 7V,#’ǁĸģȤƒ”{~,5:GƒÔ¨ÕÚ½p˜—o€jţōp˜~h–],5:G

ƒɟĮqx 7V,#†&LB‚…- %ƒ”—ÔØ˹ı›Ŀm~-L?›Ô¨ÕÚ½s—^ȃeȘƭıqx-L?†]

&.(.&›ÔØ˹ıq]voƒ̓ɢs—˸ɸjÔØ˹ıʖ˗…óːŗ˞“¥Õ°¡Î°©¿Õ…ŧœ€ˁ{

xô̈…žÖÕ§Ú°©¿Õ›øg~ʰl^o…”f‚ŭŽi‚°©¿Õ…ș˜ƒ|e~†]Śƒəqx^

o…°©¿Õø˯…ŚƗƒ|e~†]sƒŬl…ţōjd—33, 34, 35. 36, 37)^qiq]Ƽ_j,&"…,5:Gƒ

ƅŞs—o€›ɇʻqx*"…ƞĨƒ|e~†]ǧyßǜ‚ȨjŬe^

Ƽ_†]*" › 8F,( ÔËÇ¢¨°ÒØȓƒ”— % njĀƒ”–]¶Øè˗ÖÊÕ…ɇȴ˽›ɴ Ƞ Ƅpu—o€ƒƻĪqxŚ ^o…njĀƒ”— *" …ɇȴüކ]ǹˆqx̉–…ɺʔ…ŭkpÙƜƵ]

vq~ŧȊƒ†Ɲ̚›ˊ‘‚i{xŚ ŧȊ¼Ú¶†əq~e‚e^o…ɾǰ†]*"% jɺʔŧȊ›

ŊɺʔŎǦƒ̅š—°©¿Õɳƒ† Ɲ̚q‚i{xo€›əs^

% ɺʔ›Ⱥe~]*" …ɇȴüÞj ,&" …ʘ̜ɰļƩƒàg—Ɲ̚›ǹ˃qxɾǰ]% ɺʔƒhe

~ǁĸģȤƒ”—ʘ̜ɰǎĝ˽jë˪qxŚ ^o…ɾǰ†]*" † ,&" … 7V,# °©¿Õƒhm

—ʘ̜ɰļƩƒƁq~ǀĢɉƒĎlo€›əŔq~e—^ÛǗ]*" …ɇȴüÞj ,&" ….( S ȹȸ

ƒàg—Ɲ̚›ǹ˃qxɾǰ]% ɺʔ†ǁĸģȤƒhm— .( S ȹȸˋƂjǀĢp˜xŚ ^qxj {~]*" †ʘ̜ɰǀĢȁʕ€†ɀ‚– 7V,# °©¿ÕˋƂp˜— .( S ȹȸƒ|e~†ǩǭ]ĀĮɉ

‚ƞĨ›ǂ{~e—€ʏg•˜—^ŰŦŢȵ…ȹȸs—® ½¥ Ø€q~†].( S ym‚l]#&]

#& ‚jɖ•˜~e— ^îơ]o˜•…® ½¥ Ø€ *" …̅š–’ǹ˃q~ʰlƨʺj d—^

îŽˣ‹xɾǰjəs”fƒ]Ŀżýi•…°©¿Õ›ȅ€˓…áǗƒĢƣs—°©¿Õ˙Ȩ…Ğų

€q~†]®Ú¨ÇÍÔÚ¦¿Úµ- %…̅àjɁš˜—^Ăg‡]̭ɺʔ†]- % …ɇs—°©¿

՛ïq~]ɺʔȈŽx†ɺʔŧȊ€e{xɏɀ‚—ɾǰjˋƂp˜—j]o˜†ņÛ°©¿Õƒɦ›ɇ s—°©¿Õj]ÞșĞƉs—°©¿Õƒ”{~ǣɻɉ‚˳øųɇȴjɀ‚—x‘d—o€jţōp

˜~e—^*" … 7V,# °©¿Õø˯ȁǼƒhm—ĀȺȨ…ˀǯ›ˇ—ɧÛȋ̎€q~] 7V,# ģȤƒ

”–ˋƂp˜—ɺʔʸװØÔØ˹ı°©¿Õj *" … % ƒ”{~Ɲ̚p˜—iʼni›ǹ˃qx^*"

› % qx ,&" †]ǁĸģȤƒùeˋƂp˜— ?5 ñˢ…¶Øè˗…¸×°ØÔØ˹ıjˋƂ p˜‚i{xŚ ^ǏɞǢɉƒ†]̲½ɺʔŰŦŢȵ† 7V,# …ģȤƒ”{~]ɺʔjȘƭıp

˜—̏ƒ]ĿżýɎÞ]Žt]- % …Șƭıj˙o—^,&" †]v… - %€q~ &LB?=B5F9&LB jȘƭıp˜— ^v˜›˙Ȩ€q]ǽ_‚°©¿ÕĞų…ÔØ˹ı›ïq~ɺʔʃ°©¿Õj ø˯p˜]ɾǰ]ɺʔʶØè˗…¸×°ØÔØ˹ı…ŧƚjˊ‘•˜—o€jɖ•˜~e— ^ɺ ʔʶØè˗…¸×°ØÔØ˹ıƒʂe~]*" j &LB …Șƭıƒàg—Ɲ̚›ˎ‹x^&LB …Șƭı… DžǾ€q~] ǨɦƒŴŞs— B9;5G=I9E9;H@5GCELF=G9.LE…¸×°ØÔØ˹ı›ˎ‹xŚ ^ ßȘƭȱƵ… &LB † .LE jÔØ˹ıp˜~h–]˸ɸȘƭ˵ûj̐˜xǼ˨›€{~e—j] ɨ… ʘÔØ˹ı˸ɸƒ”{~ .LE …ÔØ˹jʘÔØ˹ıp˜—€ȘƭıȱƵ€‚–]°©¿ÕĞų›ÔØ˹

ıq~Þșƒ°©¿Õ›ø˯k—”fƒ‚—o€jɖ•˜~e— ^Ś ”– 1. € *"% …áɺʔ

ƒhe~]ǁĸģȤơ Ğ &LB … .LE ÔØ˹ı…Ƞƙjǹĝp˜x^o˜†ģȤƒ”–]&LB jȅƐ

ƒȘƭıp˜xo€›əq~e—^o…ɾǰ† *" …Ǿɉ€‚—Ğųj &LB …ÞșƒŴŞq]v…Ǿɉ… Û|j *"% ƒùeÔØ˹ıjˋƂp˜‚l‚{x ?5 ¶Øè˗d—łʕƭ›əq~e—^oo

efǾɉ€†Ɣʎ…Ƴŏd–]ĹŽƒ† ?5 ¶Øè˗…ÔØ˹ıƒ̅š—ÔØ˹ı˸ɸj]”–

ɎLj…Ǿɉd—łʕƭ’d—^et˜ƒq~’]o… ?5 ¶Øè˗jþd—i›ȐŸs—ç›Ƭ j„‡‚•‚e^

ŰŦŢȵ€Ì²½ɺʔ… 7V,# °©¿Õø˯…Ģƣƒ˻ʺ€p˜~e— - % €q~]&LB …ðƒ LB j ɖ•˜~h– ]̲½ɺʔ… 7V,# °©¿Õø˯ƒhe~ &LB ”–’q™ LB j˻ʺd—

€s—ţō’ŴŞs—^qiq],&" ƒ†] LB †ɇȴq~e‚e…]ǩɗɤƢ•˜xɾǰj] LB

›Ï ØƒȘȺs—ɺʔ˯’ņǽ…ɾǰjƢ•˜—iʼniƒ|e~†]ǹ˃…ÿşjd—^

7V,# °©¿Õƒhm— *" …ĀȺȨj]&LB ô̈…°©¿Õd—o€jəŔp˜xx‘]p•ƒÞ ș…°©¿Õd— '*?=B5F9 …ÔØ˹ıƒ|e~ǹ˃qx^'*?=B5F9 °©¿Õ†Ì²½ɺʔ…ʘ̜ɰ ļƩ…Ģƣ“® ½¥ Ø٪Х Ø˳øų…˞ĚȘƭı]ȸŴÙŧȊƒ̅às—°©¿Õ€q~ɖ•

˜~h–]#; ›ïqxǁĸģȤƒ”{~Șƭıjho—o€jɖ•˜~e— ^

Ś ƒəqx”fƒ]*" › % qx ,&" †]ǁĸģȤơ Ğ…ǞȨƒhe~ 1. ˊ‘•˜— ,%]

D]$(% …ÔØ˹ı…ë˪jˊ‘•˜‚i{x^o…ɾǰ† *" jĒ… *" ǾɉĞų€ɍp˜— ?5

¶Øè˗°©¿Õ…ș˜j˲Ǖp˜—€ʏg—Ƽ_…²½ÚÔڀɔɐ†q‚e^*" › % qx "9&5 ɺʔ›Ⱥexɗɤ]% ɺʔ†]! ĿżýģȤˋƂp˜— ,% …ÔØ˹ıjȠƙs—o€jţō p˜~e— ^o˜•…ţō†],% …ÝșƒŴŞs— '*%%% d— 7,5: €ɏéĀȺs—o€

ƒ”{~]*" j ! ĿżýģȤˋƂp˜— ,5F,5:'%,% ɽ˝›Ģƣq~e—€ˣ‹~e—^ǩɗɤ

ʿſp˜x ,&" ›ȺexƼ_…¼Ú¶†]1. ǁĸģȤˋƂp˜— ,% …ÔØ˹ı…j *"

% ˋƂp˜‚e€efɾǰ†]Ɵ•…ţōƒ̟úq~e—^o…o€i•]Ƽ_…Ẓ́ɳ’ 7,5: j

*" …Ǿɉ€‚{~e—łʕƭjʏg•˜—^o…Ȩƒ|e~†ÛƇ…ˀǯjƨʺd™f^ÛǗ]D “

$(% …Șƭıƒ̅q~†],5F,5:'%,% ɽ˝€†ɀ‚—ɽ˝jĢƣs—o€jɖ•˜~h– ]'*

%=B5F9 °©¿Õƒhm— *" …ĀȺȨjʹǑŴŞs—łʕƭƒ|e~’ʽ˼ƒĕ˜xɗɤjƨʺd—^

îŗooƒəqx ,&" …Ẓ́ƒ”–]*" †ŰŦŢȵ… #; ִɶڅ°©¿Õø˯ƒƝ̚›Ļ

sçjəp˜x^o…Ï¥À³Îƒ†]*"%… #; ִɶÚģȤ¸×°ØÔØ˹ı…ˋƂjŒ€œ

ˊ‘•˜‚i{x ?5 …Ğųj°©¿ÕĢƣ…˿€‚—łʕƭjəŔp˜x^o… ?5 Ğų†]

¸×°ØÔØ˹ıjˋƂp˜‚i{x…†‚l]¶Øè˗v…’……ɇȴjüÞqxłʕƭ’d—^

qiq]½Ú¶Õ¶Øè˗…ȖĮDzʢöÚ؃Ɲ̚j‚i{xo€¼Ú¶†əq~e‚e^vq~]

Ƽ_€ņrl *" … % ›Ì²½ɺʔʰ{x©ÕÚÉj]Ś ƒəqx”f‚°©¿Õ¶Øè˗…Ȫģ ȤȱƵ…ɇȴƒƁs—Ɲ̚›ˊ‘~e‚eo€‚i•]v…łʕƭ†üei’q˜‚e^Žx]o … ?5 ôū…°©¿ÕĢƣƒ”–]ǁĸģȤˋƂp˜— ,&" …ɺʔʸװØÔØ˹ı°©¿Õ Ļˆ ,%]D]$(% …ÔØ˹ıƒƝ̚s—ġÕÚ½ŴŞs—łʕƭƒ|e~†]ŽyŬl…Ẓ́jƨʺ

d—^et˜ƒu”]îŗ…Ẓ́ɾǰ†]ǽ_‚łʕƭ…â]o… ?5 Ğųj *" ɎLjŽx†̄

Lj…Ǎ˷ރd{~]°©¿Õø˯ƒ̅š—łʕƭ›əŔq~e—€ƫš˜—^îŗ†o…¶Øè˗…

ŹýȰŸƒ†ʝ•‚i{xj]ŭʝƬo…Ğų…Źý›ˀǜs—o€]*" …Ģƣs—ɖ•˜~

e‚ežÖÕ§ÚĢƣ…ˮɩjæƱp˜—^

ǩɗɤ˫ʰâƒɇʳp˜xˏǓƒhe~]%%=A •†]Ì¡²…̲½ɺʔƒhe~]*" € -L??5jɏéĀȺs—€ţōqx^Ɵ•†]*" j] 7V,# € &LB h”ˆ -L? …ʹŅý›ŶŸıq]

,5:G ƒhm—˜Ť¶Øè€q~ȁʕs—€ɾˏq~e—²¹⁾^Ƽ_…Ẓ́†]?5 ¶Øè…ÔØ˹

ıƒƌɀ†ˊ‘•˜‚i{xj]Ɵ•…Ẓ́ɾǰ†]*"% ƒùe ?5 … -L? …¸×°ØÔØ˹ıj ŷĖƒǀĢp˜~ex^%=A •†]Ì¡²̤̥Ȼǭ̲½ɺʔ›Ẓ́Ǫǔ€q~h–]Ƽ_…ŰŦŢȵɺʔ Ǵ…Ẓ́ɾǰ€ĵɶƒȌˠ†ĝǭ‚e^qiq]îơƼ_†]?5 ¶Øè˗€ ?5 … -L? …ɀņ€

ÔØ˹ıöÚ؛ƶ˻ƒȌˠǹ˃s—ƨʺjd—^qiq]et˜…ɗɤɾǰƒhe~’îŽɖ•˜

~e‚i{x 7V,# °©¿Õ… *" ƒ”—ĢƣȁǼjŴŞs—ɾǰjəp˜xo€†˻ʺd—^îơ]

*" ɗɤ…p•‚—ɖʻj] 7V,# °©¿Õø˯ȁǼ…ˈɺ‚ˀǜƒʈj—ç†̄˰e‚ey™f^îơ …ɗɤƻǰjžÖÕ§ÚˋɇȁǼ›ˀǜq]ǁžÖÕ§Úǖʫ…ĩʫƒ˔Ȳs—o€ƒǦƠqxe^

nq

ǩɗɤ…˫ʰƒƛx–]ǩŵIJŵ˵ĔɂŵǏź…ǫŀɮǏdž€ņǏź…ɊǽƒŵʱÙȯ˖…á̙Ŭl… ƣljĬ›exykŽqx^ɊǽƒƧi•ƴːexqŽs^

ཧ⪃ᩥ⊩

1. ࣐ࣜ࢘ࢳ࣭࢔ࣞࣝࢠ࣮ᑐ⟇ጤဨ఍ሗ࿌᭩, ᖹᡂ23ᖺ8᭶,ཌ⏕⛉Ꮫᑂ㆟఍⑌⑓ᑐ⟇㒊఍.

2. MacGlashan DW Jr. IgE-dependent signaling as a therapeutic target for allergies. Trends Pharmacol Sci. 2012;33(9):502-9.

3. Kawakami T, Galli SJ. Regulation of mast-cell and basophil function and survival by IgE. Nat Rev Immunol. 2002;2(10):773-86.

4. Gilfillan AM, Tkaczyk C. Integrated signalling pathways for mast-cell activation. Nat Rev Immunol. 2006;6(3):218-30.

5. Dráber P, Dráberová L. Lipid Rafts in mast cell signaling. Mol Immunol. 2002;38(16-18):1247-52.

6. Brown DA, London E. Functions of lipid Rafts in biological membranes. Annu Rev Cell Dev Biol. 1998;14:111-36.

7. Karasuyama H, Mukai K, Obata K, Tsujimura Y, Wada T. Nonredundant roles of basophils in immunity. Annu Rev Immunol.

2011;29:45-69.

8. Sokol CL, Barton GM, Farr AG, Medzhitov R. A mechanism for the initiation of allergen-induced T helper type 2 responses.

Nat Immunol. 2008;9(3):310-8.

9. Sawaguchi M, Tanaka S, Nakatani Y, Harada Y, Mukai K, Matsunaga Y, Ishiwata K, Oboki K, Kambayashi T, Watanabe N, Karasuyama H, Nakae S, Inoue H, Kubo M. Role of mast cells and basophils in IgE responses and in allergic airway hyperresponsiveness. J Immunol. 2012;188(4):1809-18.

10. Obata K, Mukai K, Tsujimura Y, Ishiwata K, Kawano Y, Minegishi Y, Watanabe N, Karasuyama H. Basophils are essential initiators of a novel type of chronic allergic inflammation. Blood. 2007;110(3):913-20.

11. Segal DM, Sharrow SO, Jones JF, Siraganian RP. Fc (IgG) receptors on rat basophilic leukemia cells. J Immunol. 1981 Jan;126(1):138-45.

12. Morita Y, Siraganian RP. Inhibition of IgE-mediated histamine release from rat basophilic leukemia cells and rat mast cells by inhibitors of transmethylation. J Immunol. 1981 Oct;127(4):1339-44.

13. McGivney A, Crews FT, Hirata F, Axelrod J, Siraganian RP. Rat basophilic leukemia cell lines defective in phospholipid methyltransferase enzymes, Ca2+ influx, and histamine release: reconstitution by hybridization. Proc Natl Acad Sci U S A. 1981 Oct;78(10):6176-80.

14. Peng Z, Beaven MA. An essential role for phospholipase D in the activation of protein kinase C and degranulation in mast cells.

Journal of Immunology. 2005;174 (9):5201-8. 16) Beaven MA, Baumgartner RA. Downstream signals initiated in mast cells by Fc epsilon RI and other receptors. Curr Opin Immunol. 1996 Dec;8(6):766-72

15. ᒣ㔝஭㐟ዲሷᇶ⌫/LSLG5DIW࡟ᒁᅾࡍࡿ᪂つ࢔ࣞࣝࢠ࣮ࢩࢢࢼࣝ㛵㐃ศᏊࡢ᥈⣴ᐩᒣ኱Ꮫ኱Ꮫ㝔ಟኈㄽᩥ

16. Nuell MJ, Stewart DA, Walker L, Friedman V, Wood CM, Owens GA, Smith JR, Schneider EL, Dell' Orco R, Lumpkin CK, et al. Prohibitin, an evolutionarily conserved intracellular protein that blocks DNA synthesis in normal fibroblasts and HeLa cells.

Mol Cell Biol. 1991 Mar;11(3):1372-81.

17. Nijtmans LG, Artal SM, Grivell LA, Coates PJ. The mitochondrial PHB complex: roles in mitochondrial respiratory complex assembly, ageing and degenerative disease. Cell Mol Life Sci. 2002 Jan;59(1):143-55.

18. Merkwirth C, Langer T. Prohibitin function within mitochondria: essential roles for cell proliferation and cristae morphogenesis.

Biochim Biophys Acta. 2009 Jan;1793(1):27-32. doi: 10.1016/j.bbamcr.2008.05.013. Epub 2008 Jun 17.

19. Osman C, Merkwirth C, Langer T. Prohibitins and the functional compartmentalization of mitochondrial membranes. J Cell Sci. 2009 Nov 1;122(Pt 21):3823-30.

20. He B, Feng Q, Mukherjee A, Lonard DM, Demayo FJ, Katzenellenbogen BS, Lydon JP, O'malley BW. A Repressive Role for Prohibitin in Estrogen Signaling. Mol Endocrinol. 2008 Feb;22(2):344-60. Epub 2007 Oct 11.

21. D. K. Kim, H. S. Kim, A.-R. Kim, G. H. Jang, H. W. Kim, Y. H. Park, B. Kim, Y. M. Park, M. A. Beaven, Y. M. Kim, W. S.

Choi, The scaffold protein prohibitinis required for antigen-stimulated signaling in mast cells. Sci. Signal.2013; 6, ra80.

22. Rajalingam K, Wunder C, Brinkmann V, Churin Y, Hekman M, Sievers C, Rapp UR, Rudel T. Prohibitin is required for Ras-induced Raf-MEK-ERK activation and epithelial cell migration. Nature Cell Biology. 2005;7 (8): 837-43.

23. Rajalingam K, Rudel T. Ras-Raf signaling needs prohibitin. Cell Cycle. 2005;4 (11): 1503-5.

24. H. Yurugi, S. Tanida, A. Ishida, K. Akita, M. Toda, M. Inoue, H. Nakada, Expression of prohibitins on the surface of activated T cells. Biochem. Biophys. Res. Commun. 2012;420, 275–280.

25. I. C. Morrow, S. Rea, S. Martin, I. A. Prior, R. Prohaska, J. F. Hancock, D. E. James, R. G. Parton, Flotillin-1/reggie-2 traffics to surface Raft domains via a novel golgi-independent pathway: Identification of a novel membrane targeting domain and a role for palmitoylation. J. Biol. Chem. 2002;277, 48834–48841.

26. ⚽࿴Ἠ⅖⑕ᛶ⑌ᝈ࡟㛵ࢃࡿ⭘⒆ቯṚᅉᏊ㸦71)㸧ࡢ⏘⏕yᨺฟ᪥ᮏ⸆⌮Ꮫ㞧ㄅVol. 121 (2003) No. 3 P 163-173 27. Abraham SN, Arock M. Mast cells and basophils in innate immunity. Semin Immunol. 1998;10(5):373-81.

28. Lock JG, Strömblad S. Systems microscopy: an emerging strategy for the life sciences. Exp Cell Res. 2010 May 1;316(8):1438-44.

29. Owen DM, Magenau A, Williamson D, Gaus K. The lipid raft hypothesis revisited--new insights on raft composition and function from super-resolution fluorescence microscopy. Bioessays. 2012 Sep;34(9):739-47.

30. van der Goot FG, Harder T. Raft membrane domains: from a liquid-ordered membrane phase to a site of pathogen attack.Semin Immunol. 2001;13(2):89-97.

31. Radeva G, Sharom FJ. Biochem J. Isolation and characterization of lipid Rafts with different properties from RBL-2H3 (rat basophilic leukaemia) cells. Biochem J. 2004;380(Pt 1):219-30.

32. Quinn PJ. A lipid matrix model of membrane Raft structure. Prog Lipid Res. 2010;49(4):390-406.

33. Holowka D, Gosse JA, Hammond AT, Han X, Sengupta P, Smith NL, Wagenknecht-Wiesner A, Wu M, Young RM, Baird B.Lipid segregation and IgE receptor signaling: a decade of progress. Biochim Biophys Acta. 2005;1746(3):252-9.

34. Peng Z, Beaven MA. An essential role for phospholipase D in the activation of protein kinase C and degranulation in mast cells.

Journal of Immunology. 2005;174 (9):5201-8.

35. Bugajev V, Bambousková M, Dráberová L, Dráber P. What precedes the initial tyrosine phosphorylation of the high affinity IgE receptor in antigen-activated mast cell? FEBS Lett. 2010;584(24):4949-55.

36. Heneberg P, Dráberová L, Bambousková M, Pompach P, Dráber P. Down-regulation of protein-tyrosine phosphatases activates an immune receptor in the absence of its translocation into lipid Rafts. J Biol Chem. 2010;285(17):12787-802.

37. Sanderson MP, Wex E, Kono T, Uto K, Schnapp A. Syk and Lyn mediate distinct Syk phosphorylation events in FcܭRI-signal transduction:implications for regulation of IgE-mediated degranulation. Mol Immunol.2010;48(1-3):171-8.

38. Min B, Brown MA, Legros G. Understanding the roles of basophils: breaking dawn. Immunology. 2012;135(3):192-7.

39. Wakahara K, Van VQ, Baba N, Bégin P, Rubio M, Delespesse G, Sarfati M. Basophils are recruited to inflamed lungs and exacerbate memory Th2 responses in mice and humans. Allergy. 2012.

40. Volná P, Lebduska P, Dráberová L, Símová S, Heneberg P, Boubelík M, Bugajev V, Malissen B, Wilson BS, Horejsí V, Malissen M, Dráber P. Negative regulation of mast cell signaling and function by the adaptor LAB/NTAL. Journal of Experimental Medicine. 2004;200 (8): 1001-13.

41.㇂࣐᪼࢘ࢫ㦵㧊⏤᮶࣐ࢫࢺ⣽⬊ࡢᶞ❧࡜ࡇࢀࢆ⏝࠸ࡓ࣐ࢫࢺ⣽⬊ࢩࢢࢼࣝࡢゎᯒᐩᒣ኱Ꮫ⸆Ꮫ㒊༞ᴗㄽᩥ

42. Shrivastava P, Katagiri T, Ogimoto M, Mizuno K, Yakura H. Dynamic regulation of Src-family kinases by CD45 in B cells.

Blood. 2004;103 (4): 1425-32.

43.Hermiston ML, Tan AL, Gupta VA, Majeti R, Weiss A. The juxtamembrane wedge negatively regulates CD45 function in B cells.

Immunity. 2005;23 (6): 635-47.

44. Parravicini V, Gadina M, Kovarova M, Odom S, Gonzalez-Espinosa C, Furumoto Y, Saitoh S, Samelson LE, O'Shea JJ, Rivera J.

Fyn kinase initiates complementary signals required for IgE-dependent mast cell degranulation. Nature Immunology. 2002;3 (8):

741-8.

45. Chan JH, Liao W, Lau HY, Wong WS. Gab2 antisense oligonucleotide blocks rat basophilic leukemic cell functions.

International Immunopharmacology 2007;7 (7): 937-44.

46. ኱ᓥ៞Ꮚᚋ㣤ሯ൉࣐ࢫࢺ⣽⬊ࡢάᛶ໬࡟㛵୚ࡍࡿ࢔ࢲࣉࢱ࣮ศᏊ࢔ࣞࣝࢠ࣮⛉ 㸸 47. Xiao W, Nishimoto H, Hong H, Kitaura J, Nunomura S, Maeda-Yamamoto M, Kawakami Y, Lowell CA, Ra C, Kawakami T.

Positive and negative regulation of mast cell activation by Lyn via the FcepsilonRI. Journal of Immunology. 2005;175(10):

6885-92.

48. Blank U, Rivera J. The ins and outs of IgE-dependent mast-cell exocytosis. Trends Immunology 2004;25 (5): 266-73. Review.

49. ᒣᮏ㞞 ௝Ἴ᠇ኴ㑻⦅ࢩࢢࢼࣝఏ㐩㞟୰࣐ࢫࢱ࣮⨺ᅵ♫

50. Fukao T, Yamada T, Tanabe M, Terauchi Y, Ota T, Takayama T, Asano T, Takeuchi T, Kadowaki T, Hata Ji J, Koyasu S.

Selective loss of gastrointestinal mast cells and impaired immunity in PI3K-deficient mice. Nature Immunology. 2002;3(3):

295-304.

ᕷ஭㈗⿱

ᐩᒣ኱Ꮫ་Ꮫ⸆Ꮫᩍ⫱㒊 ⸆࣭⏕≀Ꮫ◊✲ᐊ

㇂ ᪼

ᐩᒣ኱Ꮫ་Ꮫ⸆Ꮫᩍ⫱㒊 ⸆࣭⏕≀Ꮫ◊✲ᐊ

⻏㇂⨾♩

ᐩᒣ኱Ꮫ་Ꮫ⸆Ꮫᩍ⫱㒊 ⸆࣭⏕≀Ꮫ◊✲ᐊ

୕ᶫ㝧ᖹ

ᐩᒣ኱Ꮫ་Ꮫ⸆Ꮫᩍ⫱㒊 ⸆࣭⏕≀Ꮫ◊✲ᐊ

Ⲩ⯓ᛅ

ᐩᒣ኱Ꮫ኱Ꮫ㝔་Ꮫ⸆Ꮫ◊✲㒊 ་࣭⏕≀Ꮫᩍᐊ

∦᱒㐩㞝

ᐩᒣ኱Ꮫ኱Ꮫ㝔་Ꮫ⸆Ꮫ◊✲㒊 ⸆࣭⏕≀Ꮫ◊✲ᐊ